Male sex (HR 1.5, 95% CI 1.4–1.6), WHO clinical Stage 3 and 4, CD4 count <200 cells/μL, abnormal BMI, and anaemia were statistically significant predictors of attrition. The gene discussed is CD4; the disease is anemia.